Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice

BACKGROUND: The safety and efficacy of olmesartan 40 mg and hydrochlorothiazide (HCTZ) as a fixed-dose combination has been investigated in clinical trials leading to its approval. The aims of the present study were to confirm these data in an unselected patient population in daily practice and to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramlage, Peter, Zemmrich, Claudia, Ketelhut, Reinhard, Wolf, Wolf-Peter, Fronk, Eva-Maria, Schmieder, Roland E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769201/
https://www.ncbi.nlm.nih.gov/pubmed/24039432
http://dx.doi.org/10.2147/VHRM.S49118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769201/
https://www.ncbi.nlm.nih.gov/pubmed/24039432
http://dx.doi.org/10.2147/VHRM.S49118

Ejemplares similares